Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma

Galsky, M D; Chen, G J; Oh, W K; Bellmunt, J; Roth, B J; Petrioli, R; Dogliotti, L; Dreicer, R; Sonpavde, G (2012). Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma. Annals of oncology, 23(2), pp. 406-10. Oxford: Oxford University Press 10.1093/annonc/mdr156

Full text not available from this repository. (Request a copy)

Cisplatin-based chemotherapy is a standard treatment of metastatic urothelial carcinoma (UC), though carboplatin-based chemotherapy is frequently substituted due to improved tolerability. Because comparative effectiveness in clinical outcomes of cisplatin- versus carboplatin-based chemotherapy is lacking, a meta-analysis was carried out.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Urology

UniBE Contributor:

Roth, Beat

ISSN:

0923-7534

Publisher:

Oxford University Press

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:20

Last Modified:

17 Mar 2015 19:27

Publisher DOI:

10.1093/annonc/mdr156

PubMed ID:

21543626

Web of Science ID:

000299744400020

URI:

https://boris.unibe.ch/id/eprint/6820 (FactScience: 211850)

Actions (login required)

Edit item Edit item
Provide Feedback